Afficher la couverture 'Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial | Danese, Silvio' en grand format
/5

0 avis

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Archive ouverte

Danese, Silvio | Vermeire, Severine | d'Haens, Geert | Panés, Julian | Dignass, Axel | Magro, Fernando | Nazar, Maciej | Le Bars, Manuela | Lahaye, Marjolein | Ni, Lioudmila | Bravata, Ivana | Lavie, Frederic | Daperno, Marco | Lukáš, Milan | Armuzzi, Alessandro | Löwenberg, Mark | Gaya, Daniel | Peyrin‐biroulet, Laurent | Rocca, Rodolfo | Lopes, Susana | Caprioli, Flavio | Ardizzone, Sandro | Echarri Piudo, Ana | Gionchetti, Paolo | Roblin, Xavier | Seidler, Ursula | Andersson, David | Patel, Kamal | Desreumaux, Pierre | Saibeni, Simone | From, Gustav | Fedurco, Miroslav | Gregus, Milos | Bouhnik, Yoram | Luegering, Andreas | Cosintino, Rocco | Bunganic, Ivan | Ramos, Jaime | Aguas Peris, Mariam | Dewit, Olivier | Principi, Mariabeatrice | Wesley, Emma | Lago, Paula | Nancey, Stephane | Martín Arranz, María Dolores | Hindryckx, Pieter | Orlando, Ambrogio | Geccherle, Andrea | Annunziata, Maria Laura | Hayee, Bu'Hussain | Balaz, Jozef | Portela, Francisco | Gilletta, Cyrielle | Kucharzik, Torsten | Mínguez, Miguel | Gisbert, Javier Pérez | Casbas, Ana Gutiérrez | Louis, Edouard | Marino, Marco | Parkes, Gareth | Cummings, Fraser | Jharap, Bindia | Kjeldsen, Jens | Correia, Luís | Ministro, Paula | Ebert, Matthias | Hertervig, Erik | Staessen, Dirk | Dutré, Joris | Colard, Arnaud | Morrison, Graham | Glerup, Henning | Dahlerup, Jens Frederik | Wolfhagen, Frank | Batovsky, Marian | Molnar, Martin | Kadleckova, Barbora | Caldeira, Paulo | Laharie, David | Hebuterne, Xavier | Bonaz, Bruno | Allez, Matthieu | Fischer, Andreas | Hinojosa del Val, Joaquín Ernesto | Ciria, Miriam Mañosa | Herrera Justiniano, Jose Manuel | Soderman, Charlotte | Chandy, Rajiv | Mowat, Craig | Irving, Peter | Fallingborg, Jan | Matous, Jan | Douda, Tomas | Altwegg, Romain | Benitez, Jose Manuel | Arroyo Villarino, María Teresa | Capón, Jordi Guardiola | Vicenc, Daniel Ginard | Dewint, Pieter | Almer, Sven | Kindt, Sebastien

Edité par CCSD ; Elsevier -

Consulter en ligne

Suggestions

Du même auteur

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Archive ouverte | Danese, Silvio | CCSD

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Archive ouverte | Peyrin-Biroulet, Laurent | CCSD

International audience. There is a need to evaluate the benefit-risk ratio of current therapies in inflammatory bowel disease (IBD) patients to provide the best quality of care. The primary objective of I-CARE (IBD ...

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

Archive ouverte | Rubin, David | CCSD

International audience

Chargement des enrichissements...